Assess the Role of Remimazolam for Procedural Sedation

Remimazolam (Byfavo), a new benzodiazepine, will compete with midazolam and propofol for use in procedural sedation.

This type of sedation provides decreased consciousness to perform procedures (colonoscopy, etc) without the need to intubate.

Remimazolam is given as an IV push for sedation induction and maintenance in adults undergoing procedures lasting 30 minutes or less.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals